Colocalization analysis confirmed a shared variant with MM risk (PP > 0.8) at seven of these (ELL2, MXI1, NFIC, RNF40, SMARCD3, TNFRSF13B and WAC; Fig. 3a and Supplementary Data 19). This evidence concerns the gene SMARCD3 and Miyoshi myopathy.